Brief report · 29 Dec 2025
ArticlePublished 2018
Suspected HyÃ?¢Ã?â?¬Ã?â?¢s Law- Fast, but not That Fast!
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Drug-induced liver injury (DILI) is a major concern in clinical studies as well as in post-marketing surveillance. Several anti-infective drugs had development discontinued due to serious hepatic events- acute liver failure, including liver transplantation or death. The diagnosis of drug-induced liver injury necessitates an initial high degree of suspicion, based on circumstantial evidence. It is a step-by-step process of exclusion. Consequently, a patient in a clinical trial who experiences elevated LFTs that meet Hy’s Law criteria should have causes other than study drug carefully excluded.
Keywords
Subjects
Infectious DiseasesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Clinical Infectious Diseases: Open Access.
Brief report · 29 Dec 2025
Preventing MDROs in ICUs: A Comprehensive Approach
Commentary · 29 Dec 2025
Combating Multidrug-Resistant Organisms: A Multilayered Approach
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalClinical Infectious Diseases: Open Access
- SubjectInfectious Diseases
- BylineArticles whose byline prints “Liga Ulmane”
- BylineArticles whose byline prints “John Riefler”
- BylineArticles whose byline prints “Maxim Kosov”
- BylineArticles whose byline prints “Maxim Belotserkovsky”

